New hope for pancreatic cancer: drug combo shows promise in early trial
NCT ID NCT04888312
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 23 times
Summary
This study tests a new drug called mitazalimab combined with standard chemotherapy in people with metastatic pancreatic cancer that has spread. The goal is to see if the combination is safe and shrinks tumors. About 94 adults who have not had prior chemotherapy for this cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Bordeaux - Hôpital Haut-Lévêque,
Bordeaux, France
-
Centre Lyon Berard
Lyon, France
-
Cliniques Universitaires St-Luc
Brussels, Belgium
-
Hopital Européen Georges Pompidou
Paris, 75015, France
-
Hospital Erasme
Brussels, Belgium
-
Hospital Universitario La Paz, Madrid, Spain
Madrid, Spain
-
Hospital Universitario Miguel Servet, Zaragoza, Spain
Zaragoza, Spain
-
Hospital Universitario Ramon y Cajal, Madrid, Spain
Madrid, Spain
-
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Barcelona, Spain
-
Hospital Universitario Virgen del Rocio, Sevilla, Spain
Seville, Spain
-
Institut Paoli-Calmettes
Marseille, France
-
Institute de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France
-
UZA Antwerp
Edegem, Belgium
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
Conditions
Explore the condition pages connected to this study.